FDA Says No More Approval or Notification Requirements for Restless Leg Syndrome Treatment

The Food and Drug Administration is reclassifying nonpowered lower extremity pressure wraps as Class I devices that are not subject to premarket approval or notification requirements. The order codifies a reclassification that took effect Dec. 30, 2013, said FDA. The devices remain subject to prescription-use restrictions, it said.